Clinical Trial: Effect of systemic inflammatory response attenuating cardiopulmonary bypass strategy reduces new ischemic/embolic lesions after acute type A aortic dissection surgery: the sirA-CPB randomized clinical trial. (China)

China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of systemic inflammatory response attenuating cardiopulmonary bypass strategy reduces new ischemic/embolic lesions after acute type A aortic dissection surgery: the sirA-CPB randomized clinical trial.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130627

Registration Time: 2026/08/22

Type: Interventional study

Primary Sponsor: Xiangya Hospital Central South University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336180

Published by HT Digital Content Services with permission from Health Daily Digest....